NanoscaleVirus Trap Molecule Market - Global Industry Insights, Trends, Outlook, andOpportunity Analysis, 2018-2026
Advancement into scientificresearch has led to the emergence of new technologies that has the potential toimprove drug delivery and effectiveness. With evolution, things are becomingminiature in size, be it electronic chips, medical devices, or pharmaceuticaldrug. However, miniaturization, also referred as nanotechnology, doesn’tcompromise on the product quality and effectiveness. Instead there is improvedquality and features delivered via this technology.
Nanotechnology has a realpotential to revolutionize the medical treatment procedures, and tools makingit more personalized, effective, safe and cheaper. Nanotechnology involves researchof molecules that only 1/100th size of cancer cells but has the potential toimprove the quality of life. Significant progress has already been made innanomaterial in terms of developing targeted drug therapies. Some of thedevelopments in nanotechnology include Quantum dots that can enhance biologicalimaging for medical diagnostics, antibody-nanoparticle complex for earlydiagnosis of atherosclerosis, use of nanoscale components in molecular imaging,and regeneration or spurring the growth of nerve cells.
The Virus ‘trap’ Nanoparticle
One of the recent progresses madein nanotechnology is the technique of combating viruses before they can infectthe host cells. Researchers at Charles Stark Draper Laboratory, theMassachusetts Institute of Technology, the Univ. of Massachusetts MedicalSchool, and the Univ. of Santa Barbara have developed nanoparticles that act asviral ‘traps’ inside the human body. These molecules are surfaced with numerouscarbohydrate molecules that closely resemble those targeted by flu viruses. Theflu viruses bind to these nanotraps instead of host cell and are eliminatedfrom the body through mucus.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/44
The nanoscale viral trap moleculetechnology can also be applicable in diagnosing a viral disease. An innovativetunable device selectively traps viruses detecting them with 100 times bettersensitivity than the current available techniques. Researchers at thePennsylvania State University developed this tool that can trap virus andremove majority of the host contaminants.
The Technology is Under Research
The nanoparticle molecule iscomposed of compounds found naturally in the human body. Hence, it is safe asan inhalant, intravenous treatment, or topical solution, and inexpensive tomanufacture. Extensive benefits of this technology imply a very high commercialpotential in the treatment of viral infections. Moreover, this technology has shown to be effective in mice. Furtherresearch in this may lead to use it against HIV virus, Herpes Simplex Virus(HSV), and Respiratory Syncytial Virus (RSV), as well as bacteria and toxins.With increasing resistance to anti-viral drugs, need for novel therapies arerealized. This will further help boost the demand for nanoscale virus trapmolecules in the treatment of viral diseases.
However, there are more alternatetherapies under research which can compete with the viral trap moleculebusiness. Double-stranded RNA Activated Caspase Oligomerizer (DRACO) is ananoparticle based drug under research which is designed to detect virallyinfected cells and eradicate only those cells from the body. Few in-vivo andin-vitro trials have proven this drug to be very effective against differentviral strains. The researchers at Charles Stark Draper Laboratory believe thatthis drug will be ready for clinical trials in next three to eight years.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/nanoscale-virus-trap-molecule-market-44
Conclusion
The viral trap molecule is poisedto make contributions far beyond the therapies and tools that have beenexplored so far. Adequate funding to this research will continue to drive theefforts in commercializing this technology.
Key Developments
Increasing research anddevelopment activities related to nanoscale virus trap molecule technology isexpected to boost the market growth. For instance, in January 2019, researchersfrom Purdue University reported that heparan sulfate, a molecule used by RossRiver virus (RRV) to help them attach to cells can prevent the virus fromescaping, in the journal Virology.
In January 2018, researchers atthe University of Turin evaluated the use of cyclodextrin-based nanosponges asvehicles for antiviral drugs.
In October 2018, researchers fromFar Eastern Federal University, the Russian Academy of Sciences, and SwinburneUniversity of Technology developed a technology for trapping and chemical analysisof organic and non-organic molecules at ultra-low concentrations.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/44
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
